Stable Human 5-Lipoxygenase Enzyme Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Human 5-lipoxygenase (5-LOX) is notoriously unstable, with a short half-life and low solubility, making it challenging for handling and applications such as high throughput screening and structural analysis.
Innovation Solution
Modifications to the human 5-LOX peptide sequence, including replacing hydrophobic amino acids with less hydrophobic ones and introducing stabilizing features from more stable lipoxygenases, result in a soluble and stable form (Stable-5-LOX) with enhanced catalytic activity and longer half-life, suitable for structural analysis and inhibitor design.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If human 5-LOX is used in its native form, then enzymatic activity is maintained, but stability and solubility are poor
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of human 5-LOX, specifically replacing hydrophobic amino acids with hydrophilic ones at positions 13-14, 40-44, and 75-76. This sequence modification fundamentally alters the enzyme's stability parameters, transforming it from an unstable native form to a stable engineered form with extended half-life and improved solubility.
Solution Approach 2:
The patent creates a composite protein structure by combining the catalytic domain of human 5-LOX with stabilizing features from more stable lipoxygenase variants. The engineered enzyme incorporates conserved structural elements and stabilizing mutations from other LOX family members, resulting in a chimeric protein that maintains human 5-LOX specificity while gaining enhanced stability.
2Stability of the object's composition
If human 5-LOX is used in its native form, then catalytic function is preserved, but solubility is low
Solution Approach 1:
The patent modifies the surface properties of 5-LOX by changing amino acid parameters at specific positions. The replacement of hydrophobic residues with hydrophilic residues alters the enzyme's surface charge and polarity, significantly improving its solubility in aqueous buffers and facilitating easier handling in laboratory applications.
3Quantity of substance
If native 5-LOX is used, then biological activity is maintained, but concentration is limited due to instability
Solution Approach 1:
The patent engineering changes the stability parameters of 5-LOX through amino acid substitution, enabling the enzyme to maintain structural integrity at higher concentrations. The engineered stable-5-LOX can be concentrated to levels suitable for high-throughput screening without undergoing aggregation or degradation that limits native 5-LOX concentration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The stable form of 5-LOX retains robust enzymatic activity, allows for higher concentrations, and facilitates crystal structure determination, enabling effective high throughput screening and inhibitor design.
Implementation Method 1
Modifications to the human 5-LOX peptide sequence, including replacing hydrophobic amino acids with less hydrophobic ones and introducing stabilizing features from more stable lipoxygenases, result in a soluble and stable form (Stable-5-LOX) with enhanced catalytic activity and longer half-life
Implementation Method 2
Lipoxygenases are a family of non-heme iron dioxygenases that catalyze the stereo- and regio-specific formation of fatty acid hydroperoxides from polyunsaturated fatty acids
Implementation Method 3
5-LOX catalyzes the peroxidation of arachidonic acid (AA) at the C5 position
Implementation Method 4
The first step of a LOX-catalyzed reaction is hydrogen abstraction at the central carbon of a pentadiene moiety by the activated Fe3+ to produce a free radical intermediate
Implementation Method 5
hydrogen abstraction at the central carbon of a pentadiene moiety by the activated Fe3+ to produce a free radical intermediate
Implementation Method 6
the subsequent transformation of the 5-hydroperoxyeicosatetraenoic acid (5-HPETE) to leukotriene A4, in which one of the oxygen atoms of the hydroperoxide ends up in an epoxide
Data Source
AI summary
A soluble and stable form of 5-lipoxygenase (5-LOX) has been made, 5-Lox is the enzyme which initiates leukotriene biosynthesis by catalyzing the two-step transformation of arachidomc acid to leukotriene A4 (LTA4). The soluble and stable 5-LOX is suitable for a number of applications, including, but not limited to, high throughput screening of 5-LOX inhibitors, structural analysis of the enzyme's active site, designing inhibitors based on the three-dimensional structure of the enzyme's active site, and synthesis of LTA4. Using Stable-5-LOX, the crystal structure for 5-LOX has been resolved and the amino acids defining the active site determined.